With Serbia making further progress with the EU accession process and the prospect of joining the EU in 2025, it is the country which gets increased attention of international pharmaceutical and medical device manufacturers.
ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016. Prices for pharmaceutical products in Kazakhstan have also increased 6.6 percent over the last 12 months.
NEWS REGULATORY CONSULTING PHARMACOVIGILANCE SERVICES MARKET ACCESS SERVICES MARKETING AND SALES Romania on the last place in EU for medical drugs consumption Romania is at the bottom of a European ranking regarding the consumption of medical drugs per capita, but not because they are healthier, but due to the precarious access to therapeutic solutions, according…
“Due to strict regulations and legislatory monitoring no falsified or unauthorized medication has entered the legal drug supply chain in Hungary until now, stated the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM).
NEWS REGULATORY CONSULTING PHARMACOVIGILANCE SERVICES MARKET ACCESS SERVICES MARKETING AND SALES Overview of Estonian medicinal products market Estonian annual drug statistics is based on wholesalers’ quarterly reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. WHOLESALERS In January 2018 there were…
Azerbaijan offers Jordan to establish a joint pharmaceutical factory, Jordan Economy Ministry said on Feb. 21.
To protect the EU pharmaceutical market from the entry of falsified medicines, the European Medicines Verification Organisation (EMVO) was created as a joint initiative of EU stakeholders, representing manufacturers, wholesalers and community pharmacists.
Slovakia’s approved Amendment to Act no. 595/2003 Coll. on Income Tax (ITA) and approved Amendment to Act no. 222/2004 Coll. on Value Added Tax (VATA), bring significant changes to the tax laws, effective 1 January 2018, which may affect pharmaceutical companies. The most relevant of these changes are:
The State Institute for Drug Control in Czech Republic (SUKL) has published the information with regard to reporting of registration holder pursuant to Section 33, paragraph 2 of Act on Pharmaceuticals. It draws the attention to the obligations set out in Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (hereinafter…
The Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM) has welcomed the fact that the size of the pharmaceutical budget (the price subsidy for medicinal products available in pharmacies) will increase according to the draft budget for 2018. According to the draft legislation, the size of the pharma budget will be 337.4 billion forints ($1.22 billion),…